All lobbying filings

Crossroads Strategies, LLC

Crossroads Strategies, LLC filed a Q4 report for Indivior Inc. on January 19, 2026, reporting $50,000 in lobbying income.

Lobbying for Indivior Inc. · pharmaceutical company

As filed: CROSSROADS STRATEGIES, LLC for INDIVIOR INC.

All filings by Crossroads Strategies, LLC · Everything Indivior Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Pharmacy

Issues related to overdose reversal products including Naloxone; FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.5304/S.2587); FY2026 Commerce, Justice, Science, and Related Agencies Appropriations Act (H.R.5342/S.2354).

Medicare/Medicaid

Medicaid policies related to substance use disorder.

Bills named in this filing 4

H.R. 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S. 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
H.R. 5342
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
S. 2354
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.